Profusa Inc.
Organization details
- Legal name
- Profusa Inc.
- Former names
- NorthView Acquisition Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PFSA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001859807
- EIN
- 86-3437271
Board of directors
-
Ben Chung-Bin Hwang · Director · Chief Executive OfficerSince 2025
-
Jack E. Stover · DirectorSince 2026
-
Lauren Chung · DirectorSince 2026
-
Peter O'Rourke · DirectorSince 2026
-
Rajesh Asarpota · DirectorSince 2025
Chief executives
Director election results
Annual meeting of March 21, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
100.0%
-
100.0%
-
100.0%
Board connections
2 of this board's directors also sit on 3 other boards. 3 are in the same sector.
-
Quantum Cyber N.V. Same sectorvia Peter O'Rourke
-
TransCode Therapeutics Inc. Same sectorvia Jack E. Stover
-
Traws Pharma Inc. Same sectorvia Jack E. Stover
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $36,929
- 8 purchases by 1 insider
- Sold, last 12 months
- $153,308
- 6 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 2026 | Knechtel Fred S. Officer (Chief Financial Officer) | Other | +54,323 | — | — |
| Aug 21, 2026 | Jack E. Stover Officer (Chief Executive Officer) | Other | +32,018 | — | — |
| Aug 21, 2026 | Knechtel Fred S. Officer (Chief Financial Officer) | Other | −301,991 | — | — |
| Aug 21, 2026 | Jack E. Stover Officer (Chief Executive Officer) | Other | −301,991 | — | — |
| Aug 17, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −18,395 | $5.94 | $109,266 |
| Aug 14, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −3,163 | $0.90 | $2,847 |
| Aug 13, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −42,411 | $0.89 | $37,746 |
| Aug 12, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +5,585 | $0.96 | $5,362 |
| Aug 12, 2026 | Knechtel Fred S. Officer (Chief Financial Officer) | Derivative conversion | +301,991 | $4.28 | $1,292,521 |
| Aug 12, 2026 | Jack E. Stover Officer (Chief Executive Officer) | Derivative conversion | +301,991 | $4.28 | $1,292,521 |
| Aug 11, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −2,280 | $0.97 | $2,212 |
| Aug 10, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +4,016 | $0.94 | $3,775 |
| Aug 7, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −924 | $0.95 | $878 |
| Aug 6, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +926 | $0.94 | $870 |
| Aug 5, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −383 | $0.94 | $360 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Profusa Inc.
Who is the CEO of Profusa Inc.?
Ben Chung-Bin Hwang has been Profusa Inc.'s Chief Executive Officer since July 2025.
How many directors are on Profusa Inc.'s board?
Profusa Inc.'s board has 5 directors: Ben Chung-Bin Hwang, Jack E. Stover, Lauren Chung, Peter O'Rourke and Rajesh Asarpota.
Are Profusa Inc. insiders buying or selling shares?
Over the last 12 months, Profusa Inc. insiders bought $36,929 of shares in 8 purchases and sold $153,308 of shares in 6 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="profusa-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.